senktide has been researched along with raclopride in 1 studies
| Studies (senktide) | Trials (senktide) | Recent Studies (post-2010) (senktide) | Studies (raclopride) | Trials (raclopride) | Recent Studies (post-2010) (raclopride) |
|---|---|---|---|---|---|
| 292 | 1 | 50 | 1,802 | 132 | 419 |
| Protein | Taxonomy | senktide (IC50) | raclopride (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Homo sapiens (human) | 0.052 | |
| D(2) dopamine receptor | Mus musculus (house mouse) | 0.032 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Couture, R; De Brito Gariepy, H | 1 |
1 other study(ies) available for senktide and raclopride
| Article | Year |
|---|---|
Blockade of tachykinin NK3 receptor reverses hypertension through a dopaminergic mechanism in the ventral tegmental area of spontaneously hypertensive rats.
Topics: Animals; Benzazepines; Blood Pressure; Dopamine; Haloperidol; Heart Rate; Hypertension; Ibotenic Acid; Indoles; Male; Oligopeptides; Peptide Fragments; Quinolines; Raclopride; Rats; Rats, Inbred SHR; Receptors, Neurokinin-3; Substance P; Ventral Tegmental Area | 2010 |